Morepen Laboratories (NSE:MOREPENLAB) EV-to-Revenue : 1.43 (As of May. 15, 2024)

View and export this data going back to 1999. Start your Free Trial

What is Morepen Laboratories EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Morepen Laboratories's enterprise value is ₹23,342 Mil. Morepen Laboratories's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₹16,275 Mil. Therefore, Morepen Laboratories's EV-to-Revenue for today is 1.43.

The historical rank and industry rank for Morepen Laboratories's EV-to-Revenue or its related term are showing as below:

NSE:MOREPENLAB' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.48 Med: 1.32 Max: 6.38
Current: 1.43

During the past 13 years, the highest EV-to-Revenue of Morepen Laboratories was 6.38. The lowest was 0.48. And the median was 1.32.

NSE:MOREPENLAB's EV-to-Revenue is ranked better than
69.79% of 1026 companies
in the Drug Manufacturers industry
Industry Median: 2.4 vs NSE:MOREPENLAB: 1.43

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-15), Morepen Laboratories's stock price is ₹46.40. Morepen Laboratories's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ₹32.43. Therefore, Morepen Laboratories's PS Ratio for today is 1.43.

Morepen Laboratories EV-to-Revenue Historical Data

The historical data trend for Morepen Laboratories's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Morepen Laboratories EV-to-Revenue Chart

Morepen Laboratories Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

EV-to-Revenue

Get a 7-Day Free Trial

1.03

0.51

1.21

1.14

0.93

Morepen Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial															1.36	0.93	1.02	1.22	1.52

Competitive Comparison of Morepen Laboratories's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Morepen Laboratories's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Morepen Laboratories's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Morepen Laboratories's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Morepen Laboratories's EV-to-Revenue falls into.

Morepen Laboratories EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Morepen Laboratories's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	23341.841	/	16274.69
	=	1.43

Morepen Laboratories's current Enterprise Value is ₹23,342 Mil.
Morepen Laboratories's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹16,275 Mil.

Morepen Laboratories (NSE:MOREPENLAB) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Morepen Laboratories's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	46.40	/	32.43
	=	1.43

Morepen Laboratories's share price for today is ₹46.40.
Morepen Laboratories's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹32.43.

Morepen Laboratories EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Morepen Laboratories's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Morepen Laboratories (NSE:MOREPENLAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Morepen Laboratories Ltd (NSE:MOREPENLAB) » Definitions » EV-to-Revenue

Traded in Other Exchanges

500288:India

Address

2nd Floor, Tower C, DLF Cyber Park, Udyog Vihar-III, Sector 20, Gurugram, HR, IND, 122016

Website

https://www.morepen.com

Morepen Laboratories Ltd is an India based pharmaceutical company. It develops, manufactures and markets generic drugs and pharmaceutical formulations. The company's products includes Tablets, Capsules, Injections, Ointments, Syrups, and Powders. It also offers products under brands Burnol, Lemolate and Fiber-X. The company's geographical markets include India, the United States and the rest of the world, with a majority of revenue being generated in India.

Morepen Laboratories (NSE:MOREPENLAB) Headlines

No Headlines